AUTHOR=Riou Margot Charlotte , de La Dure-Molla Muriel , Kerner Stéphane , Rondeau Sophie , Legendre Adrien , Cormier-Daire Valerie , Fournier Benjamin P. J.
TITLE=Oral Phenotype of Singleton–Merten Syndrome: A Systematic Review Illustrated With a Case Report
JOURNAL=Frontiers in Genetics
VOLUME=13
YEAR=2022
URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.875490
DOI=10.3389/fgene.2022.875490
ISSN=1664-8021
ABSTRACT=Background: Singleton–Merten syndrome type 1 (SGMRT1) is a rare autosomal dominant disorder caused by IFIH1 variations with blood vessel calcifications, teeth anomalies, and bone defects.
Aim: We aimed to summarize the oral findings in SGMRT1 through a systematic review of the literature and to describe the phenotype of a 10-year-old patient with SGMRT1 diagnosis.
Results: A total of 20 patients were described in the literature, in nine articles. Eight IFIH1 mutations were described in 11 families. Delayed eruption, short roots, and premature loss of permanent teeth were the most described features (100%). Impacted teeth (89%) and carious lesions (67%) were also described. Our patient, a 10-year-old male with Singleton–Merten syndrome, presented numerous carious lesions, severe teeth malposition, especially in the anterior arch, and an oral hygiene deficiency with a 100% plaque index. The panoramic X-ray did not show any dental agenesis but revealed very short roots and a decrease in the jaw alveolar bone height. The whole-genome sequencing analysis revealed a heterozygous de novo variant in IFIH1 (NM_022168.4) c.2465G > A (p.Arg822Gln).
Conclusion: Confused descriptions of oral features occurred in the literature between congenital findings and “acquired” pathology, especially carious lesions. The dental phenotype of these patients encompasses eruption anomalies (delayed eruption and impacted teeth) and lack of root edification, leading to premature loss of permanent teeth, and it may contribute to the diagnosis. An early diagnosis is essential to prevent teeth loss and to improve the quality of life of these patients.
Systematic Review Registration: [https://www.crd.york.ac.uk/prospero/], identifier [CRD42022300025].